(Q43249137)

17 November 2017

title

Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome (English)

1 reference

polycystic ovary syndrome

17 November 2017

main subject

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

based on heuristic

inferred from title

non-alcoholic fatty liver

1 reference

1 reference

1 reference

1 reference

E Vassilatou

1

1 reference

17 November 2017

S Lafoyianni

2

1 reference

17 November 2017

A Vryonidou

3

1 reference

17 November 2017

D Ioannidis

4

1 reference

17 November 2017

L Kosma

5

1 reference

17 November 2017

K Katsoulis

6

1 reference

17 November 2017

E Papavassiliou

7

1 reference

17 November 2017

I Tzavara

8

1 reference

17 November 2017

language of work or name

English

0 references

publication date

3 November 2009

1 reference

17 November 2017

1 reference

17 November 2017

volume

25

1 reference

17 November 2017

issue

1

1 reference

17 November 2017

page(s)

212-220

1 reference

Nonalcoholic fatty liver disease

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Ultrasound assessment of the polycystic ovary: international consensus definitions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Polycystic ovary syndrome and severe nonalcoholic steatohepatitis: beneficial effect of modest weight loss and exercise on liver biopsy findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

The metabolic syndrome in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

The androgenic sex hormone profile is an essential feature of metabolic syndrome in premenopausal women: a controlled community-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Prevalence and predictors of dyslipidemia in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Polycystic ovary syndrome is associated with endothelial dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Updated definitions of healthy ranges for serum alanine aminotransferase levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Abnormal aminotransferase activity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Nonalcoholic steatohepatitis and nonalcoholic Fatty liver disease in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Review: The role of insulin resistance in nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Association of hyperandrogenemic and metabolic phenotype with carotid intima-media thickness in young women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

Low sex hormone-binding globulin is associated with the metabolic syndrome in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMREP%2FDEP380

21 January 2018

Identifiers

DOI

10.1093/HUMREP/DEP380

1 reference

17 November 2017

1 reference